Akhmed Aslam
About
Akhmed Aslam is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine.
According to data from OpenAlex, Akhmed Aslam has authored 38 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Akhmed Aslam's work include Peptidase Inhibition and Analysis (4 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Cancer-related gene regulation (3 papers). Akhmed Aslam is often cited by papers focused on Peptidase Inhibition and Analysis (4 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Cancer-related gene regulation (3 papers). Akhmed Aslam collaborates with scholars based in Saudi Arabia, Egypt and United Kingdom. Akhmed Aslam's co-authors include G. Sebastiaan Winkler, Saloni Mittal, Jean‐Christophe Andrau, Frédéric Koch, Ahmed M. Gouda, Ashraf N. Abdalla, Bassem Refaat, Andrew F. Walls, Shakir Idris and Jawwad Ahmad and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and PLoS ONE.
In The Last Decade
Akhmed Aslam
36 papers receiving 904 citations
Peers
Akhmed Aslam
Hamid Tanzadehpanah Iran
Jing Deng China
Matthew J. McKay Australia
Xueji Wu China
Wei‐Chun HuangFu Taiwan
Marianna G. Yakubovskaya Russia
Pavel Spirin Russia
Gilles A. Robichaud Canada
Miranda Wilson United Kingdom
Yunbae Pak South Korea
Citations per year, relative to Akhmed Aslam Akhmed Aslam (= 1×)
peers
Hamid Tanzadehpanah
Countries citing papers authored by Akhmed Aslam
Since
Specialization
Citations
This map shows the geographic impact of Akhmed Aslam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akhmed Aslam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akhmed Aslam more than expected).
Fields of papers citing papers by Akhmed Aslam
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Akhmed Aslam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akhmed Aslam. The network helps show where Akhmed Aslam may publish in the future.
Co-authorship network of co-authors of Akhmed Aslam
This figure shows the co-authorship network connecting the top 25 collaborators of Akhmed Aslam. A scholar is included among the top collaborators of Akhmed Aslam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akhmed Aslam. Akhmed Aslam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Aslam, Akhmed, Faisal Minshawi, Hussain A. Almasmoum, et al.. (2025). Exploring potential additive effects of 5-fluorouracil, thymoquinone, and coenzyme Q10 triple therapy on colon cancer cells in relation to glycolysis and redox status modulation. Journal of the Egyptian National Cancer Institute. 37(1). 7–7.
2.
Aslam, Akhmed, Bassem Refaat, Riyad A. Almaimani, et al.. (2025). Increased protein expression of interleukin-10 and its signalling molecules in colon cancer progression: potential prognostic and therapeutic targets. Discover Oncology. 16(1). 637–637.
3.
Almaimani, Riyad A., Shakir Idris, Akhmed Aslam, et al.. (2023). Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus. International Journal of Molecular Sciences. 24(24). 17380–17380.
4.
Kabrah, Saeed, Samer Abuzerr, Raed Alserihi, et al.. (2023). The Quality of Blood Donation Services and Its Association with Blood Donors’ Trust and Loyalty at Makkah Blood Donation Centers in Saudi Arabia: A Cross-Sectional Study. Healthcare. 11(15). 2115–2115.
5.
Refaat, Bassem, Akhmed Aslam, Shakir Idris, et al.. (2023). Profiling estrogen, progesterone, and androgen receptors in colorectal cancer in relation to gender, menopausal status, clinical stage, and tumour sidedness. Frontiers in Endocrinology. 14. 1187259–1187259.
6.
Almaimani, Riyad A., Akhmed Aslam, Jawwad Ahmad, et al.. (2022). In Vivo and In Vitro Enhanced Tumoricidal Effects of Metformin, Active Vitamin D3, and 5-Fluorouracil Triple Therapy against Colon Cancer by Modulating the PI3K/Akt/PTEN/mTOR Network. Cancers. 14(6). 1538–1538.
7.
Idris, Shakir, Bassem Refaat, Riyad A. Almaimani, et al.. (2022). Enhanced in vitro tumoricidal effects of 5-Fluorouracil, thymoquinone, and active vitamin D3 triple therapy against colon cancer cells by attenuating the PI3K/AKT/mTOR pathway. Life Sciences. 296. 120442–120442.
8.
Alghamdi, Saad, Muhammad Umar Khayam Sahibzada, Nashwa Talaat Shesha, et al.. (2022). Pneumococcal Surface Protein A: A Promising Candidate for the Next Generation of Pneumococcal Vaccines. Cellular and Molecular Biology. 67(4). 289–298.
9.
Al‐kuraishy, Hayder M., Ali I. Al‐Gareeb, Gomaa Mostafa‐Hedeab, et al.. (2021). Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19. Frontiers in Immunology. 12. 749291–749291.
10.
Mohamed, Amr M., et al.. (2020). Group B streptococcus colonization, antibiotic susceptibility, and serotype distribution among Saudi pregnant women. Infection and Chemotherapy. 52(1). 70–70.
11.
Aslam, Akhmed, Jawwad Ahmad, Mohammed Baghdadi, et al.. (2020). Chemopreventive effects of vitamin D3 and its analogue, paricalcitol, in combination with 5-fluorouracil against colorectal cancer: The role of calcium signalling molecules. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1867(3). 166040–166040.
12.
Abdalla, Ashraf N., Akhmed Aslam, Muhammad Ahmed, et al.. (2019). Ethyl benzoate bearing pyrrolizine/indolizine moieties: Design, synthesis and biological evaluation of anti-inflammatory and cytotoxic activities. Bioorganic Chemistry. 94. 103371–103371.
13.
Gouda, Ahmed M., Hoda A. El‐Ghamry, Tahani M. Bawazeer, et al.. (2018). Antitumor activity of pyrrolizines and their Cu(II) complexes: Design, synthesis and cytotoxic screening with potential apoptosis-inducing activity. European Journal of Medicinal Chemistry. 145. 350–359.
14.
Collins, Hilary M., Magdy K. Abdelghany, Marie C. Messmer, et al.. (2013). Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells. BMC Cancer. 13(1). 37–37.
15.
Mittal, Saloni, et al.. (2012). The Anti-Proliferative Activity of BTG/TOB Proteins Is Mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) Deadenylase Subunits of the Ccr4-Not Complex. PLoS ONE. 7(12). e51331–e51331.
16.
Mittal, Saloni, et al.. (2011). The Ccr4a (CNOT6) and Ccr4b (CNOT6L) deadenylase subunits of the human Ccr4–Not complex contribute to the prevention of cell death and senescence. Molecular Biology of the Cell. 22(6). 748–758.
17.
Aslam, Akhmed, Saloni Mittal, Frédéric Koch, Jean‐Christophe Andrau, & G. Sebastiaan Winkler. (2009). The Ccr4–Not Deadenylase Subunits CNOT7 and CNOT8 Have Overlapping Roles and Modulate Cell Proliferation. Molecular Biology of the Cell. 20(17). 3840–3850.
18.
Aslam, Akhmed, P M Quinn, Richard S. McIntosh, et al.. (2007). Proteases from Schistosoma mansoni cercariae cleave IgE at solvent exposed interdomain regions. Molecular Immunology. 45(2). 567–574.
19.
Shintani, Satoru, et al.. (2006). P53-dependent radiosensitizing effects of Hsp90 inhibitor 17-Allylamino-17-demethoxygeldanamycin on human oral squamous cell carcinoma cell lines. International Journal of Oncology. 29(5). 1111–7.
20.
He, Shaoheng, Akhmed Aslam, Marianna Gaça, et al.. (2004). Inhibitors of Tryptase as Mast Cell-Stabilizing Agents in the Human Airways: Effects of Tryptase and Other Agonists of Proteinase-Activated Receptor 2 on Histamine Release. Journal of Pharmacology and Experimental Therapeutics. 309(1). 119–126.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Hamid Tanzadehpanah Breakdown of academic impact, for papers by Jing Deng Breakdown of academic impact, for papers by Matthew J. McKay Breakdown of academic impact, for papers by Xueji Wu Breakdown of academic impact, for papers by Wei‐Chun HuangFu Breakdown of academic impact, for papers by Marianna G. Yakubovskaya Breakdown of academic impact, for papers by Pavel Spirin Breakdown of academic impact, for papers by Gilles A. Robichaud Breakdown of academic impact, for papers by Miranda Wilson Breakdown of academic impact, for papers by Yunbae Pak